Citations (84)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (20)
Ede Frecska, Csaba
E. Móré, András Vargha & Luis
E. Luna. (2012) Enhancement of Creative Expression and Entoptic Phenomena as After-Effects of Repeated Ayahuasca Ceremonies. Journal of Psychoactive Drugs 44:3, pages 191-199.
Read now
Read now
Max J. Henderson & John D.C. Mellers. (2000) Psychosis in Parkinson’s disease: ‘between a rock and a hard place’. International Review of Psychiatry 12:4, pages 319-334.
Read now
Read now
H.A. Abramson. (1960) Lysergic Acid Diethylamide (LSD-25): XXX. the Questionnaire Technique with Notes on its Use. The Journal of Psychology 49:1, pages 57-65.
Read now
Read now
H.A. Abramson. (1959) Lysergic Acid Diethylamide (LSD-25): XXIX. The Response Index as a Measure of Threshold Activity of Psychotropic Drugs in Man. The Journal of Psychology 48:1, pages 65-78.
Read now
Read now
H.A. Abramson, M.P. Hewitt, H. Lennard, W.J. Turner, F.J. O'neill & S. Merlis. (1958) The Stablemate Concept of Therapy as Affected by LSD in Schizophrenia. The Journal of Psychology 45:1, pages 75-84.
Read now
Read now
LippmanH. Geronimus, HaroldA. Abramson & LauraJ. Ingraham. (1956) Lysergic Acid Diethylamide (Lsd-25): Xxiii. Comparative Effects of Lsd-25 and Related Ergot Drugs on Brain Tissue Respiration and on Human Behavior. The Journal of Psychology 42:1, pages 157-168.
Read now
Read now
H. Lennard, M.E. Jarvik & H.A. Abramson. (1956) Lysergic Acid Diethylamide (LSD-25): XII. A Preliminary Statement of its Effects Upon Interpersonal Communication. The Journal of Psychology 41:1, pages 185-198.
Read now
Read now
H.A. Abramson, M.E. Jarvik, M.H. Gorin & M.W. Hirsch. (1956) Lysergic Acid Diethylamide (LSD-25): XVII. Tolerance Development and its Relationship to a Theory of Psychosis. The Journal of Psychology 41:1, pages 81-105.
Read now
Read now
M.W. Hirsch, M.E. Jarvik & H.A. Abramson. (1956) Lysergic Acid Diethylamide (LSD-25): XVIII. Effects of LSD-25 and Six Related Drugs upon Handwriting. The Journal of Psychology 41:1, pages 11-22.
Read now
Read now
H.A. Abramson, M.E. Jarvik, A. Levine, M.R. Kaufman & M.W. Hirsch. (1955) Lysergic Acid Diethylamide (Lsd-25): Xv. the Effects Produced By Substitution of a Tap Water Placebo. The Journal of Psychology 40:2, pages 367-383.
Read now
Read now
A. Levine, H.A. Abramson, H.A. Abramson, S. Markham & C. Kornetsky. (1955) Lysergic Acid Diethylamide (Lsd-25): Xiv. Effect on Personality as Observed in Psychological Tests. The Journal of Psychology 40:2, pages 351-366.
Read now
Read now
H.A. Abramson, S.E. Waxenberg, A. Levine, M.R. Kaufman & C. Kornetsky. (1955) Lysergic Acid Diethylamide (Lsd-25) Xiii. Effect on Bender-Gestalt Test Performance. The Journal of Psychology 40:2, pages 341-349.
Read now
Read now
H.A. Abramson, C. Kornetsky, M.E. Jarvik, M.R. Kaufman & M.W. Ferguson. (1955) Lysergic Acid Diethylamide (Lsd-25): Xi. Content Analysis of Clinical Reactions. The Journal of Psychology 40:1, pages 53-60.
Read now
Read now
H.A. Abramson, M.E. Jarvik & M.W. Hirsch. (1955) Lysergic Acid Diethylamide (Lsd-25): X. Effect on Reaction Time to Auditory and Visual Stimuli. The Journal of Psychology 40:1, pages 39-52.
Read now
Read now
M.E. Jarvik, H.A. Abramson, M.W. Hirsch & A.T. Ewald. (1955) Lysergic Acid Diethylamide (LSD-25): VIII. Effect on Arithmetic Test Performance. The Journal of Psychology 39:2, pages 465-473.
Read now
Read now
H.A. Abramson, M.E. Jarvik & M.W. Hirsch. (1955) Lysergic Acid Diethylamide (LSD-25): VII. Effect upon Two Measures of Motor Performance. The Journal of Psychology 39:2, pages 455-464.
Read now
Read now
M.E. Jarvik, H.A. Abramson & M.W. Hirsch. (1955) Lysergic Acid Diethylamide (LSD-25): VI. Effect upon Recall and Recognition of Various Stimuli. The Journal of Psychology 39:2, pages 443-454.
Read now
Read now
H.A. Abramson, M.E. Jarvik, M.W. Hirsch & A.T. Ewald. (1955) Lysergic Acid Diethylamide (LSD-25): V. Effect on Spatial Relations Abilities. The Journal of Psychology 39:2, pages 435-442.
Read now
Read now
M.E. Jarvik, H.A. Abramson & M.W. Hirsch. (1955) Lysergic Acid Diethylamide (LSD-25): IV. Effect on Attention and Concentration. The Journal of Psychology 39:2, pages 373-383.
Read now
Read now
HaroldA. Abramson. (1955) Lysergic Acid Diethylamide (LSD-25): III. As an Adjunct to Psychotherapy with Elimination of Fear of Homosexuality. The Journal of Psychology 39:1, pages 127-155.
Read now
Read now
Articles from other publishers (64)
Erika Dyck & Gregory P. Marchildon. (2023) A history and future of psychedelics: The case of the Canadian military. Journal of Military, Veteran and Family Health 9:5, pages 71-79.
Crossref
Crossref
Marco Solmi, Chaomei Chen, Charles Daure, Anne Buot, Michael Ljuslin, Vincent Verroust, Luc Mallet, Yasser Khazaal, Stephane Rothen, Gabriel Thorens, Daniele Zullino, Gabriella Gobbi, Joshua Rosenblat, Muhammad Ishrat Husain, Danilo De Gregorio, David Castle & Michel Sabé. (2022) A century of research on psychedelics: A scientometric analysis on trends and knowledge maps of hallucinogens, entactogens, entheogens and dissociative drugs. European Neuropsychopharmacology 64, pages 44-60.
Crossref
Crossref
Alice Wong & Amir Raz. (2022) Microdosing with classical psychedelics: Research trajectories and practical considerations. Transcultural Psychiatry 59:5, pages 675-690.
Crossref
Crossref
Kurt Stocker. (2022) Seeing in Visionary and Mystical Experience: A Perceptual and Cognitive-Semantic Account. Cognitive Semantics 8:2, pages 323-344.
Crossref
Crossref
K. Stocker, G. Hasler & M. Hartmann. (2021) Letter to the editor: Are ketamine-induced subjective bodily experiences associated with antidepressant effects? A sensation of floating and a sensation of lightness are not the same – A comment on Acevedo-Diaz et al.. Journal of Psychiatric Research 137, pages 454-455.
Crossref
Crossref
Jay A. Olson, Léah Suissa-Rocheleau, Michael Lifshitz, Amir Raz & Samuel P. L. Veissière. (2020) Tripping on nothing: placebo psychedelics and contextual factors. Psychopharmacology 237:5, pages 1371-1382.
Crossref
Crossref
Laura Stark & Nancy D Campbell. (2018) The ineffable: A framework for the study of methods through the case of mid-century mind-brain sciences. Social Studies of Science 48:6, pages 789-820.
Crossref
Crossref
Sean J. Belouin & Jack E. Henningfield. (2018) Psychedelics: Where we are now, why we got here, what we must do. Neuropharmacology 142, pages 7-19.
Crossref
Crossref
Blanca Spee, Tomohiro Ishizu, Helmut Leder, Jan Mikuni, Hideaki Kawabata & Matthew Pelowski. 2018. The Arts and The Brain - Psychology and Physiology Beyond Pleasure. The Arts and The Brain - Psychology and Physiology Beyond Pleasure
343
372
.
T. T. Schmidt & Tomislav Majić. 2018. Handbuch Psychoaktive Substanzen. Handbuch Psychoaktive Substanzen
153
171
.
Rainer Kraehenmann, Dan Pokorny, Leonie Vollenweider, Katrin H. Preller, Thomas Pokorny, Erich Seifritz & Franz X. Vollenweider. (2017) Dreamlike effects of LSD on waking imagery in humans depend on serotonin 2A receptor activation. Psychopharmacology 234:13, pages 2031-2046.
Crossref
Crossref
Matthew Oram. (2016) Prohibited or regulated? LSD psychotherapy and the United States Food and Drug Administration. History of Psychiatry 27:3, pages 290-306.
Crossref
Crossref
David Vearrier, Laura Vearrier, Rita McKeever, Jolene Okaneku, Gregory LaSala, David Goldberger & Kristin McCloskey. (2016) Issues in driving impairment. Disease-a-Month 62:4, pages 72-116.
Crossref
Crossref
T. Buchborn, G. Grecksch, D.C. Dieterich & V. Höllt. 2016. Neuropathology of Drug Addictions and Substance Misuse. Neuropathology of Drug Addictions and Substance Misuse
846
858
.
Timo Torsten Schmidt & Tomislav Majić. 2016. Handbuch Psychoaktive Substanzen. Handbuch Psychoaktive Substanzen
1
25
.
Nancy D. Campbell & Laura Stark. (2015) Making up ‘Vulnerable’ People: Human Subjects and the Subjective Experience of Medical Experiment. Social History of Medicine 28:4, pages 825-848.
Crossref
Crossref
M. E. Sutter, J. Chenoweth & T. E. Albertson. (2013) Alternative Drugs of Abuse. Clinical Reviews in Allergy & Immunology 46:1, pages 3-18.
Crossref
Crossref
Anthony G. Romano, Jennifer L. Quinn, Luchuan Li, Kuldip D. Dave, Emmanuelle A. Schindler, Vincent J. Aloyo & John A. Harvey. (2010) Intrahippocampal LSD accelerates learning and desensitizes the 5-HT2A receptor in the rabbit, Romano et al.. Psychopharmacology 212:3, pages 441-448.
Crossref
Crossref
Torsten Passie, John H. Halpern, Dirk O. Stichtenoth, Hinderk M. Emrich & Annelie Hintzen. (2008) The Pharmacology of Lysergic Acid Diethylamide: A Review. CNS Neuroscience & Therapeutics 14:4, pages 295-314.
Crossref
Crossref
S. L. Walsh, A. E. Chausmer, E. C. Strain & G. E. Bigelow. (2007) Evaluation of the mu and kappa opioid actions of butorphanol in humans through differential naltrexone blockade. Psychopharmacology 196:1, pages 143-155.
Crossref
Crossref
John A. Harvey. (2003)
Role of the Serotonin 5-HT
2A
Receptor in Learning
. Learning & Memory 10:5, pages 355-362.
Crossref
Crossref
. 2002. Addiction. Addiction
72
84
.
Daniel X. Freedman. 1992. The Mosaic of Contemporary Psychiatry in Perspective. The Mosaic of Contemporary Psychiatry in Perspective
182
190
.
T. F. Meert, P. de Haes & P. A. J. Janssen. (1989) Risperidone (R 64 766), a potent and complete LSD antagonist in drug discrimination by rats. Psychopharmacology 97:2, pages 206-212.
Crossref
Crossref
Charles A. Haertzen & John E. Hickey. 1987. Methods of Assessing the Reinforcing Properties of Abused Drugs. Methods of Assessing the Reinforcing Properties of Abused Drugs
489
524
.
F. C. Colpaert, T. F. Meert, C. J. E. Niemegeers & P. A. J. Janssen. (1985) Behavioral and 5-HT antagonist effects of ritanserin: A pure and selective antagonist of LSD discrimination in rat. Psychopharmacology 86:1-2, pages 45-54.
Crossref
Crossref
Barry L. Jacobs & Michael E. Trulson. 1978. The Psychopharmacology of Hallucinogens. The Psychopharmacology of Hallucinogens
220
240
.
Barry L. Jacobs. (1978) Dreams and hallucinations: A common neurochemical mechanism mediating their phenomenological similarities. Neuroscience & Biobehavioral Reviews 2:1, pages 59-69.
Crossref
Crossref
A. Fanchamps. 1978. Ergot Alkaloids and Related Compounds. Ergot Alkaloids and Related Compounds
567
614
.
Michael E. Trulson & Barry L. Jacobs. (1977) Usefulness of an animal behavioral model in studying the duration of action of LSD and the onset and duration of tolerance to LSD in the cat. Brain Research 132:2, pages 315-326.
Crossref
Crossref
Barry L. Jacobs, Michael E. Trulson & Warren C. Stern. (1977) Behavioral effects of LSD in the cat: Proposal of an animal behavior model for studying the actions of hallucinogenic drugs. Brain Research 132:2, pages 301-314.
Crossref
Crossref
Michael E. Trulson, Arlene D. Stark & Barry L. Jacobs. (1977) Comparative effects of hallucinogenic drugs on rotational behavior in rats with unilateral 6-hydroxydopamine lesions. European Journal of Pharmacology 44:2, pages 113-119.
Crossref
Crossref
W. R. Martin & J. W. Sloan. 1977. Drug Addiction II. Drug Addiction II
305
368
.
Barry L. Jacobs, Michael E. Trulson & Warren C. Stern. (1976) An Animal Behavior Model for Studying the Actions of LSD and Related Hallucinogens. Science 194:4266, pages 741-743.
Crossref
Crossref
Donald R. Jasinski, Charles A. Haertzen & Harris Isbell. (2006) REVIEW OF THE EFFECTS IN MAN OF MARIJUANA AND TETRAHYDROCANNABINOLS ON SUBJECTIVE STATE AND PHYSIOLOGIC FUNCTIONING. Annals of the New York Academy of Sciences 191:1, pages 196-205.
Crossref
Crossref
Herbert Weingartner, Solomon H. Snyder & Louis A. Faillace. (2013) DOM (STP), A New Hallucinogenic Drug: Specific Perceptual Changes. The Journal of Clinical Pharmacology and New Drugs 11:2, pages 103-111.
Crossref
Crossref
S. Sharma, S. Cohen, A. M. KarrowJr.Jr., M. W. Riley, R. P. Alquist, J. W. McFarland, H. Uehleke, O. Wintersteiner, A. Burger & E. R. GarretSidney Cohen. 1971. Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des Recherches Pharmaceutiques. Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des Recherches Pharmaceutiques
68
102
.
L. Molinengo & S. Ricci-Gamalero. (1970) Action of codeine, pethidine and methadone on the operant behavior of the rat. Psychopharmacologia 17:1, pages 34-48.
Crossref
Crossref
R. Fischer. 1970. Origin and Mechanisms of Hallucinations. Origin and Mechanisms of Hallucinations
303
332
.
Harris Isbell & D. R. Jasinski. (1969) A comparison of LSD-25 with (?)-?9-trans-tetrahydrocannabinol (THC) and attempted cross tolerance between LSD and THC. Psychopharmacologia 14:2, pages 115-123.
Crossref
Crossref
Akira Shimizu & Harold E. Himwich. (2004) Effect of LSD on the sleep cycle of the developing kitten. Developmental Psychobiology 1:1, pages 60-64.
Crossref
Crossref
M. Vojtěchovský, D. Krus, S. Grof, V. Vítek, K. RyŠènek, K. Kunz & J. Skèla. 1968. Anticholinergic Drugs and Brain Functions in Animals and Man. Anticholinergic Drugs and Brain Functions in Animals and Man
86
105
.
A. Hoffer & H. Osmond. 1967. The Hallucinogens. The Hallucinogens
237
265
.
HAROLD E. HIMWICH. 1967. Amines and Schizophrenia. Amines and Schizophrenia
137
149
.
Harris Isbell & C. W. Gorodetzky. (1965) Effect of alkaloids of ololiuqui in man. Psychopharmacologia 8:5, pages 331-339.
Crossref
Crossref
C.M.B. Pare & Elwood H. LaBrosse. (1963) A further study on alleviation of the psychological effects of LSD in man by pretreatment with 5-hydroxytryptophan. Journal of Psychiatric Research 1:4, pages 271-277.
Crossref
Crossref
Charles A. Haertzen, Harris E. Hill & Richard E. Belleville. (1963) Development of the Addiction Research Center Inventory (ARCI): Selection of items that are sensitive to the effects of various drugs. Psychopharmacologia 4:3, pages 155-166.
Crossref
Crossref
Alan M. Hartman & Leo E. Hollister. (1963) Effect of mescaline, lysergic acid diethylamide and psilocybin on color perception. Psychopharmacologia 4:6, pages 441-451.
Crossref
Crossref
Leo E. Hollister & Alan M. Hartman. (1962) Mescaline, lysergic acid diethylamide and psilocybin: Comparison of clinical syndromes, effects on color perception and biochemical measures. Comprehensive Psychiatry 3:4, pages 235-241.
Crossref
Crossref
A. B. WolbachJr.Jr., E. J. Miner & Harris Isbell. (1962) Comparison of psilocin with psilocybin, mescaline and LSD-25. Psychopharmacologia 3:3, pages 219-223.
Crossref
Crossref
Leo E. Hollister. (2006) DRUG‐INDUCED PSYCHOSES AND SCHIZOPHRENIC REACTIONS: A CRITICAL COMPARISON *. Annals of the New York Academy of Sciences 96:1, pages 80-93.
Crossref
Crossref
A. B. WolbachJr.Jr., Harris Isbell & E. J. Miner. (1962) Cross tolerance between mescaline and LSD-25 with a comparison of the mescaline and LSD reactions. Psychopharmacologia 3:1, pages 1-14.
Crossref
Crossref
F. Hertle, K. E. Zipf & H. Broghammer. (1961) Beobachtungen �ber Stoffwechselverhalten, Muskeltonus und einige Kreislaufgr��en beim Menschen unter LSD-25-Einwirkung. Archiv f�r Psychiatrie und Nervenkrankheiten Vereinigt mit Zeitschrift f�r die Gesamte Neurologie und Psychiatrie 202:6, pages 569-591.
Crossref
Crossref
Harold A. Abramson. (2018) Lysergic Acid Diethylamide (LSD-25). Journal of Mental Science 106:444, pages 1120-1123.
Crossref
Crossref
Santo Salvatore. (1960) Some related factors of the LSD 25 reaction. The Psychiatric Quarterly 34:2, pages 236-251.
Crossref
Crossref
Joseph R. Bertino, Gerald D. Klee & Walter Weintraub. (2018) Effects of Certain Vitamins and Histamines on the Lsd Psychosis. Journal of Mental Science 105:441, pages 1095-1099.
Crossref
Crossref
Harris Isbell, E. J. Miner & C. R. Logan. (1959) Cross tolerance between d-2-brom-lysergic acid diethylamide (BOL-148) and the d-diethylamide of lysergic acid (LSD-25). Psychopharmacologia 1:2, pages 109-116.
Crossref
Crossref
Harris Isbell. (1959) Comparison of the reactions induced by psilocybin and LSD-25 in man. Psychopharmacologia 1:1, pages 29-38.
Crossref
Crossref
Harris Isbell, E. J. Miner & C. R. Logan. (1959) Relationships of psychotomimetic to anti-serotonin potencies of congeners of lysergic acid diethylamide (LSD-25). Psychopharmacologia 1:1, pages 20-28.
Crossref
Crossref
H. A. Abramson, B. Sklarofsky, M. O. Baron & N. Fremont-Smith. (1957) Production of Tolerance to Psychosis-Producing Doses of Lysergic Acid Diethylamide. Science 126:3281, pages 1020-1020.
Crossref
Crossref
Derrick S. Trouton. (2018) Placebos and their Psychological Effects. Journal of Mental Science 103:431, pages 344-354.
Crossref
Crossref
Louis Sokoloff, Seymour Perlin, Conan Kornetsky & Seymour S. Kety. (2010) THE EFFECTS OF D‐LYSERGIC ACID DIETHYLAMIDE ON CEREBRAL CIRCULATION AND OVER‐ALL METABOLISM. Annals of the New York Academy of Sciences 66:3, pages 468-477.
Crossref
Crossref
Wolfgang de BoorWolfgang de Boor. 1956. Pharmakopsychologie und Psychopathologie. Pharmakopsychologie und Psychopathologie
141
183
.
Harold A. Abramson & Llewellyn T. Evans. (1954) Lysergic Acid Diethylamide (LSD 25): II. Psychobiological Effects on the Siamese Fighting Fish. Science 120:3128, pages 990-991.
Crossref
Crossref